FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to phthisiology, and can be used for prediction of pulmonary tuberculosis. Method of prediction of clinical course of tuberculosis, including determination of concentration of taurine in blood plasma, wherein concentration of taurine in monocytes is additionally determined, thereafter ratio of concentration of taurine in plasma to concentration of taurine in monocytes is analyzed, and if ratio is from 0.5 to 0.69, probability of infiltrative tuberculosis is predicted, if ratio is from 0.7 to 1, probability of developing tuberculoma is predicted, if it is above 1, probability of developing cystic cavernous tuberculosis is predicted.
EFFECT: method described above enables more reliable prediction of clinical course of tuberculosis.
1 cl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING RECURRENCE OF PULMONARY TUBERCULOSIS | 2020 |
|
RU2762671C1 |
METHOD OF DETERMINING THE TIMING OF SURGICAL INTERVENTION WHEN USING SHORT COURSES OF CHEMOTHERAPY FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2798945C1 |
METHOD OF REDUCING INTOLERANCE TO ANTITUBERCULOUS PREPARATIONS | 2009 |
|
RU2412701C2 |
METHOD FOR MONITORING SERUM CONCENTRATIONS OF BEDAQUILINE FOR ASSESSING EFFECTIVENESS OF ANTI-TUBERCULOSIS CHEMOTHERAPY | 2024 |
|
RU2831888C1 |
METHOD FOR CORRECTION OF TREATMENT OF PATIENTS WITH TUBERCULOSIS WITHOUT BACTERIOEXCRETION BY X-RAY EXAMINATION DATA | 2015 |
|
RU2625649C2 |
METHOD OF TREATING PULMONARY AND BRONCHIAL TUBERCULOSIS IN VARIOUS X-RAY SYNDROMES | 2023 |
|
RU2826098C1 |
METHOD FOR DETERMINING DURATION OF CHEMOTHERAPY OF RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND WIDE MTB DRUG RESISTANCE IN CHILDREN AND TEENAGERS | 2018 |
|
RU2680972C1 |
METHOD OF PREDICTING INCREASE OF VOLUME OF PULMONARY TISSUE INJURY AT INFILTRATIVE TUBERCULOSIS | 2016 |
|
RU2633077C1 |
METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS COMBINED WITH DIABETES MELLITUS | 2023 |
|
RU2825182C1 |
METHOD FOR PREDICTION OF LETHAL OUTCOME IN CLINICAL COURSE OF COINFECTION OF HIV AND TUBERCULOSIS, ACCOMPANIED BY MULTIPLE DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS | 2019 |
|
RU2710266C1 |
Authors
Dates
2017-03-15—Published
2015-06-29—Filed